Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

BACKGROUND: There is debate over using tenofovir or zidovudine alongside lamivudine in second-line antiretroviral therapy (ART) following stavudine failure. We analyzed outcomes in cohorts from South Africa, Zambia and Zimbabwe METHODS: Patients aged ≥16 years who switched from a first-line regimen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wandeler, Gilles, Gerber, Florian, Rohr, Julia, Chi, Benjamin H, Orrell, Catherine, Chimbetete, Cleophas, Prozesky, Hans, Boulle, Andrew, Hoffmann, Christopher J, Gsponer, Thomas, Fox, Matthew P, Zwahlen, Marcel, Egger, Matthias
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4043936/
https://ncbi.nlm.nih.gov/pubmed/24296645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2710
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items